Abiomed, Inc. (ABMD)

Growth

Revenue 5Y17.13%
Revenue 3Y9.84%
EPS 5Y20.04%
EPS 3Y-19.54%
Dividend 5Y-
Dividend 3Y-

Capital Efficiency

ROIC16.23%
ROE17.75%
ROA15.72%
ROTA16.20%

Capital Structure

Market Cap17.18B
EV0
Cash182.34M
Current Ratio7.93
Debt/Equity0.09
Net Debt/EBITDA-0.39
Show More

Income Statement

Select a metric from the list below to chart it

Mar '87
Mar '94
Mar '01
Mar '08
Mar '15
Mar '22
Income Statement
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
TTM
Revenue
183.6
230.3
329.5
445.3
593.7
769.4
840.9
847.5
1,031.8
1,074.1
Revenue % Chg.
16.1%
25.4%
43.1%
35.1%
33.3%
29.6%
9.3%
0.8%
21.7%
10.3%
Cost of Revenue
37.3
39.9
50.4
70.6
98.6
129.6
151.3
161.9
188.2
200.6
Cost of Revenue % Chg.
18.1%
7.0%
26.2%
40.1%
39.6%
31.4%
16.8%
7.0%
16.2%
13.8%
Gross Profit
146.3
190.4
279.1
374.7
495.2
639.9
689.6
685.6
843.6
873.5
Gross Profit % Chg.
15.6%
30.1%
46.6%
34.2%
32.2%
29.2%
7.8%
-0.6%
23.0%
9.5%
Gross Profit Margin
79.7%
82.7%
84.7%
84.1%
83.4%
83.2%
82.0%
80.9%
81.8%
81.3%
Gross Profit Margin % Chg.
-0.4%
3.7%
2.5%
-0.7%
-0.9%
-0.3%
-1.4%
-1.4%
1.1%
-0.7%
R&D Expenses
30.7
36.0
49.8
66.4
75.3
93.5
98.8
121.9
163.4
167.2
R&D Expenses % Chg.
19.7%
17.1%
38.3%
33.4%
13.4%
24.2%
5.6%
23.4%
34.1%
16.3%
Selling, General, & Admin Expenses
107.3
125.7
164.3
218.2
262.7
321.6
341.6
334.2
423.5
452.2
Selling, General, & Admin Expenses % Chg.
27.3%
17.2%
30.6%
32.8%
20.4%
22.4%
6.2%
-2.2%
26.7%
15.1%
Operating Income
8.4
28.7
65.1
90.1
157.1
224.8
249.2
229.6
140.7
253.6
Operating Income % Chg.
-49.4%
242.8%
127.1%
38.5%
74.3%
43.1%
10.9%
-7.9%
-38.7%
74.5%
Operating Income Margin
4.6%
12.4%
19.8%
20.2%
26.5%
29.2%
29.6%
27.1%
13.6%
23.6%
Operating Income Margin % Chg.
-56.5%
173.3%
58.7%
2.5%
30.7%
10.4%
1.4%
-8.6%
-49.6%
58.2%
Total Other Income/Expenses Net
0.2
0.1
0.7
1.2
3.3
38.5
7.6
58.7
49.8
87.6
Total Other Income/Expenses Net % Chg.
-47.6%
-40.7%
641.4%
64.2%
173.9%
1068.1%
-80.3%
671.3%
-15.0%
31.0%
Income Before Tax
8.5
28.8
65.8
91.3
160.4
263.4
256.8
288.2
190.6
341.2
Income Before Tax % Chg.
-49.4%
237.2%
128.9%
38.7%
75.6%
64.2%
-2.5%
12.2%
-33.9%
60.8%
Income Before Tax Margin
4.6%
12.5%
20.0%
20.5%
27.0%
34.2%
30.5%
34.0%
18.5%
31.8%
Income Before Tax Margin % Chg.
-56.4%
168.9%
60.0%
2.7%
31.7%
26.7%
-10.8%
11.3%
-45.7%
45.8%
Income Tax Expense
1.2
-84.9
27.7
39.2
48.3
4.3
53.8
62.7
54.1
74.4
Income Tax Expense % Chg.
-36.2%
-
-
41.7%
23.0%
-91.0%
1138.9%
16.5%
-13.8%
18.1%
Net Income
7.4
113.7
38.1
52.1
112.2
259.0
203.0
225.5
136.5
266.8
Net Income % Chg.
-51.0%
1446.6%
-66.4%
36.6%
115.2%
130.9%
-21.6%
11.1%
-39.5%
78.9%
Net Income Margin
4.0%
49.4%
11.6%
11.7%
18.9%
33.7%
24.1%
26.6%
13.2%
24.8%
Net Income Margin % Chg.
-57.8%
1133.2%
-76.5%
1.1%
61.4%
78.2%
-28.3%
10.2%
-50.3%
62.1%
Weighted Avg. Shares Out
39.3
40.6
42.2
43.2
44.2
44.9
45.2
45.1
45.4
45.5
Weighted Avg. Shares Out % Chg.
0.6%
3.3%
3.9%
2.5%
2.1%
1.7%
0.6%
-0.1%
0.7%
0.4%
EPS
0.2
2.8
0.9
1.2
2.5
5.8
4.5
5.0
3.0
5.9
EPS % Chg.
-50.0%
1373.7%
-67.9%
34.4%
109.9%
127.2%
-22.2%
11.4%
-40.0%
78.7%
Weighted Avg. Shares Out Dil
41.6
42.9
44.9
44.7
45.8
46.2
45.8
45.7
45.9
45.9
Weighted Avg. Shares Out Dil % Chg.
1.3%
3.0%
4.8%
-0.5%
2.7%
0.7%
-0.7%
-0.3%
0.5%
0.4%
EPS Diluted
0.2
2.7
0.9
1.2
2.5
5.6
4.4
4.9
3.0
5.8
EPS Diluted % Chg.
-51.4%
1372.2%
-67.9%
37.6%
109.4%
129.0%
-21.0%
11.5%
-39.7%
79.6%
Interest Income
-
-
-
-
-
-
-
-
49.8
-
Interest Expense
-
-
-
-
-
-
-
-
49.8
-
EBIT
8.5
28.8
65.8
91.3
160.4
263.4
256.8
288.2
190.6
341.2
EBIT % Chg.
-49.4%
237.2%
128.9%
38.7%
75.6%
64.2%
-2.5%
12.2%
-33.9%
60.8%
EBIT Margin
4.6%
12.5%
20.0%
20.5%
27.0%
34.2%
30.5%
34.0%
18.5%
31.8%
EBIT Margin % Chg.
-56.4%
168.9%
60.0%
2.7%
31.7%
26.7%
-10.8%
11.3%
-45.7%
45.8%
Depreciation & Amortization
2.5
2.8
3.3
6.2
11.0
14.1
20.4
24.1
28.1
27.6
Depreciation & Amortization % Chg.
-7.9%
10.4%
18.3%
89.3%
77.4%
28.3%
44.7%
17.9%
16.6%
2.7%
EBITDA
11.0
31.5
69.1
97.5
171.4
277.5
277.3
312.3
218.6
368.7
EBITDA % Chg.
-43.6%
185.7%
119.2%
41.1%
75.8%
61.9%
-0.1%
12.6%
-30.0%
54.3%
EBITDA Margin
6.0%
13.7%
21.0%
21.9%
28.9%
36.1%
33.0%
36.9%
21.2%
34.3%
EBITDA Margin % Chg.
-51.5%
127.8%
53.2%
4.4%
31.8%
24.9%
-8.6%
11.8%
-42.5%
39.9%